ACAD
NASDAQ
US
ACADIA Pharmaceuticals Inc. - Common Stock
$22.20
▼ $-0.12
(-0.54%)
Vol 1.7M
9
Quality Score
ok
Deep Check
1/5
fail
Rev ✓
NI ✗
>IPO ✗
Mkt Cap
$4.5B
P/E
17.3
ROE
32.3%
Margin
30.2%
D/E
0.00
Beta
0.69
52W
$13–$28
Wall Street Consensus
27 analysts · Apr 20267
Strong Buy
14
Buy
5
Hold
1
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
APGE
Apogee Therapeutics Inc
$5.2B
DNTH
Dianthus Therapeutics Inc
$1.8B
FOLD
Amicus Therapeutics Inc
$4.4B
VKTX
Viking Therapeutics Inc
$4.0B
SYRE
Spyre Therapeutics Inc
$2.5B
LEGN
Legend Biotech Corp
$4.0B
DNLI
Denali Therapeutics Inc
$2.6B
DYN
Dyne Therapeutics Inc
$3.2B
TNGX
Tango Therapeutics Inc
$1.2B
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.14 | $1.60 | +$1.46 |
| Sep 2025 | $0.15 | $0.42 | +$0.27 |
| Jun 2025 | $0.14 | $0.16 | +$0.02 |
| Mar 2025 | $0.11 | $0.11 | $0.00 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 28.6% | 30.7% | 30.7% | 30.7% | 32.3% | 32.3% |
| P/E (TTM) | 19.18 | 18.95 | 16.29 | 17.24 | 16.47 | 17.30 |
| Net Margin | 10.1% | 26.2% | 26.2% | 26.2% | 30.2% | 30.2% |
| Gross Margin | 92.2% | 92.1% | 92.1% | 92.1% | 92.0% | 92.0% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.91 | 2.91 | 2.91 | 2.91 | 3.02 | 3.02 |
Key Ratios
ROA (TTM)
21.4%
P/S (TTM)
5.63
P/B
4.2
EPS (TTM)
$1.55
CF/Share
$-0.88
52W High
$28.35
52W Low
$13.40
$13.40
52-Week Range
$28.35
How does ACAD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ACAD valuation vs Biotechnology peers
P/E ratio
17.3
▼
8%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
5.6
▼
56%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
4.2
▲
69%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ACAD profitability vs Biotechnology peers
ROE
32.3%
▲
148%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
30.2%
▲
111%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
92.0%
▲
17%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
21.4%
▲
146%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
ACAD financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.0
▼
32%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
▼
29%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
ACAD fundamentals radar
ACAD
Peer median
Industry
ACAD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ACAD vs peers: key metrics
Latest News
Is Acadia Healthcare Company, Inc. (ACHC) A Good Stock To Buy Now?
Yahoo Finance · Mar 21
Academy Sports and Outdoors Q4 Earnings Call Highlights
Yahoo Finance · Mar 19
Academy Shares Fall After Q4 Miss
Yahoo Finance · Mar 19
Academy Sports and Outdoors, Inc. Q4 2025 Earnings Call Summary
Yahoo Finance · Mar 17